Abstract 1163: Preclinical investigation of ADCT-242, a novel exatecan-based antibody drug conjugate targeting Claudin-6, as single agent or in combination in ovarian and non-small lung cancer models
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Nicola Tsang, Elizabeth Horsley, Narinder Janghra, Chris Pickford, Lolke de Haan, Patrick H. van Berkel
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409624274
